Clinical Trial Update: A Trial of Rosuvastatin in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

This clinical trial update confirms completion of a Phase 2 study of rosuvastatin in Systemic Lupus Erythematosus. The study also lists atherosclerosis as an as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Systemic Lupus Erythematosus

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Imperial College London | Conditions: Atherosclerosis, Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED